Light Chain Bioscience (Switzerland)

Light Chain Bioscience (Switzerland)

Novimmune is a privately held Swiss pharmaceutical development company focusing on monoclonal antibody therapies for treatment of immune-related diseases. The company was founded in 1998. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Light Chain Bioscience (Switzerland), Switzerland, covering academic research published from 2002 to 2024. Read More.


Open Access Percentage

64%


Total
Publications

302


Total Open
Publications

194


Total
Citations

15K


Open Access
Percentage

64%


Total
Publications

302


Total Open
Publications

194


Total
Citations

15K

Wikipedia

Website

download

Breakdown

17% 38% 9% 36%

Publisher Open

17%

Both

38%

Other Platform Open

9%

Closed

36%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02468101214161820222426Total Publications
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

43%OA Journal

OA Journal 43%

71

Hybrid 20%

34

No Guarantees 37%

62

Other Platform Open

Domain 84%

119

Institution 36%

51

Public 12%

17

Other Internet 7%

10

Preprint 4%

6

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
121
Europe PMC
Domain
77
University of Zurich - Zurich Open Repository and Archive
Institution
17
Figshare
Public
17
Semantic Scholar
Public
15
University of Geneva - Archive ouverte UNIGE
Institution
13
ETH Zurich - Repository for Publications and Research Data
Institution
10
DOI
Other Internet
5
Le Centre pour la Communication Scientifique Directe - HAL - Inserm
Institution
4
bioRxiv
Preprint
4
1 / 6

Data updated 7 April 2025

Share

Share

Share